Showing 471-480 of 3356 results for "".
Exploring Dupilumab's Impact on Growth in Pediatric Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/exploring-dupilumabs-impact-on-growth-in-pediatric-atopic-dermatitis/50962/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Michelle Tarbox, MD, FAAD, discuss emerging evidence and real-world experiences demonstrating how effective control of atopic dermatitis with dupilumab may support healthy growth and development in pediatric patiePractical Dermatology Roundtable: Reclaiming Urticaria, Ch. 4
https://practicaldermatology.com/programs/practical-dermatology/practical-dermatology-roundtable-reclaiming-urticaria-ch-4/84989/In the fourth installment of this five-part series, Brad P. Glick, DO, MPH, FAAD; Laura K. Ferris, MD, PhD; and Lawrence J. Green, MD, FAAD, discuss the quality-of-life burden of CSU, practical antihistamine escalation, and how to choose among injectable and oral targeted therapies.Practical Dermatology Roundtable: Reclaiming Urticaria, Ch. 2
https://practicaldermatology.com/programs/practical-dermatology/practical-dermatology-roundtable-reclaiming-urticaria-ch-2/84987/In the second installment of this five-part series, Brad P. Glick, DO, MPH, FAAD; Laura K. Ferris, MD, PhD; and Lawrence J. Green, MD, FAAD review key diagnostic clues that distinguish CSU from urticarial vasculitis and inducible urticaria, while addressing angioedema and practical treatment optionsPractical Dermatology Roundtable: Reclaiming Urticaria, Ch. 3
https://practicaldermatology.com/programs/practical-dermatology/practical-dermatology-roundtable-reclaiming-urticaria-ch-3/84988/In the third installment of this five-part series, Brad P. Glick, DO, MPH, FAAD; Laura K. Ferris, MD, PhD; and Lawrence J. Green, MD, FAAD, examine the immunologic pathways underlying CSU, including mast-cell activation, IgE and IgG mechanisms, BTK inhibition, and distinctions from chronic inducibleTreatment Approaches for Psoriatic Arthritis
https://practicaldermatology.com/programs/practical-dermatology-il-17-journal-club/treatment-approaches-for-psoriatic-arthritis/48809/Naeim T. Issa, MD, PhD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss the Mediterranean Journal of Rheumatology article “Emerging Targets in Psoriatic Arthritis: Dual IL-17A/F and Selective TYK2 Inhibition in a Clinical Perspective.”Journal Club: Colloidal Oat for Prevention and Treatment
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-colloidal-oat-for-prevention-and-treatment/32407/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Editorial Board member Lawrence Eichenfield, MD, FAAD, discuss a study demonstrating the benefits of oat for infant skincare, especially for the treatment and mitigation of atopic dermatitis.Mechanisms of Action for IL-17 Inhibition in Treating Psoriasis and Hidradenitis Suppurativa
https://practicaldermatology.com/programs/practical-dermatology-il-17-journal-club/mechanisms-of-action-for-il-17-inhibition-in-treating-psoriasis-and-hidradenitis-suppurativa/48808/Practical Dermatology Editorial Board member Jason E. Hawkes, MD, MS, FAAD, joins Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss articles from the Journal of Clinical Medicine and Clinics in Dermatology on how IL-17 inhibition is effective in treating psoriasis and hidradenitis suppurativa,Radiesse for Hands, Alevicyn Cleared
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-radiesse-for-hands-alevicyn-cleared/18898/Merz gets FDA approval for Radiesse for hand augmentation and releases data comparing Xeomin to Botox. Heidi Waldorf, MD, FAAD and Michael Gold, MD, FAAD, comment. Also in this edition, Galderma participate in a White House forum on antibiotic stewardship, and the FDA gives 510(k) clearance to AleviPrurigo Nodularis, Chronic Itch, and Lymphoma Risk
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/prurigo-nodularis-chronic-itch-and-lymphoma-risk/50965/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Lawrence Green, MD, FAAD, examine the link between prurigo nodularis, chronic pruritus, Type 2 inflammation, and lymphoma risk, with a focus on evaluating the underlying causes of persistent itch.Navigating the Latest Therapeutic Options
https://practicaldermatology.com/issues/october-2025/navigating-the-latest-therapeutic-options/39762/A Q&A With Raj Chovatiya, MD, PhD, MSCI, FAAD